MCM
AVNS

MAI Capital Management’s Avanos Medical AVNS Stock Holding History

MAI Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-115
Closed -$1.61K – 2296
2026
Q1 		$1.61K Buy
115
+55
+92% +$741 ﹤0.01% 4013
2025
Q4 		$674 Buy
60
+45
+300% +$515 ﹤0.01% 3755
2025
Q3 		$174 Sell
15
-76
-84% -$890 ﹤0.01% 3723
2025
Q2 		$1.11K Hold
91
– – ﹤0.01% 3591
2025
Q1 		$1.3K Sell
91
-68
-43% -$1.06K ﹤0.01% 3065
2024
Q4 		$2.53K Buy
+159
New +$3.15K ﹤0.01% 2973

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

MAI Capital Management's AVNS Position: Q2 2026 in Review

MAI Capital Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 115 shares — an estimated $1.61K sold.

MAI Capital Management first reported a position in AVNS in Q4 2024 and held it in 6 quarters. The position peaked at $2.53K in Q4 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • MAI Capital Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 115 Avanos Medical shares in Q2 2026, an estimated $1.61K.
  • MAI Capital Management first reported a position in Avanos Medical in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Avanos Medical position peaked at $2.53K in Q4 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.